(Q39388561)

11 September 2017

PAX7-FKHR fusion gene inhibits myogenic differentiation via NF-kappaB upregulation (English)

1 reference

11 September 2017

0 references

7

1 reference

11 September 2017

5

Marc Ladanyi

1 reference

11 September 2017

6

Carlos Cordon-Cardo

1 reference

11 September 2017

2

Igor Matushansky

1 reference

PubMed ID

22374423

11 September 2017

Elizabeth Charytonowicz

series ordinal

1

object named as

Elizabeth Charytonowicz

1 reference

11 September 2017

Josep Domingo Doménech

series ordinal

3

1 reference

PubMed ID

22374423

11 September 2017

Mireia Castillo-Martín

series ordinal

4

1 reference

11 September 2017

1 March 2012

1 reference

Clinical and Translational Oncology

11 September 2017

1 reference

11 September 2017

14

1 reference

11 September 2017

197-206

1 reference

11 September 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1007/s12094-012-0784-4

11 September 2017

0 references

cites work

Gene fusions involving PAX and FOX family members in alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

The COOH-terminal transactivation domain plays a key role in regulating the in vitro and in vivo function of Pax3 homeodomain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Missing pieces in the NF-kappaB puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappaB in solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

IKK/NF-kappaB regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Alternate PAX3 and PAX7 C-terminal isoforms in myogenic differentiation and sarcomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Pax3 activation promotes the differentiation of mesenchymal stem cells toward the myogenic lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Expression of the FUS-CHOP fusion protein in primary mesenchymal progenitor cells gives rise to a model of myxoid liposarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

In vivo amplification of the PAX3-FKHR and PAX7-FKHR fusion genes in alveolar rhabdomyosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappa B: ten years after

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappaB as a potential molecular target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Akt is a downstream target of NF-kappa B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Coupling of the cell cycle and myogenesis through the cyclin D1-dependent interaction of MyoD with cdk4

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Regulation of promyogenic signal transduction by cell-cell contact and adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

A developmental model of sarcomagenesis defines a differentiation-based classification for liposarcomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Alveolar rhabdomyosarcoma: is the cell of origin a mesenchymal stem cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Basic fibroblast growth factor in human rhabdomyosarcoma cells: implications for the proliferation and neovascularization of myoblast-derived tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-012-0784-4

Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development.

21 January 2018

1 reference

12 December 2020

Identification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models

1 reference

12 December 2020

Genetic heterogeneity in the alveolar rhabdomyosarcoma subset without typical gene fusions

1 reference

12 December 2020

Mouse mesenchymal stem cells expressing PAX-FKHR form alveolar rhabdomyosarcomas by cooperating with secondary mutations

1 reference

12 December 2020

LY 294002, an inhibitor of phosphatidylinositol 3-kinase, inhibits GH-mediated expression of the IGF-I gene in rat hepatocytes

1 reference

12 December 2020

Ewing's sarcoma origin: from duel to duality

1 reference

12 December 2020

Rhabdomyosarcomas in adults and children: an update

1 reference

12 December 2020

Ewing tumor fusion proteins block the differentiation of pluripotent marrow stromal cells.

1 reference

12 December 2020

Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay

1 reference

12 December 2020

Wild type PAX3 protein and the PAX3-FKHR fusion protein of alveolar rhabdomyosarcoma contain potent, structurally distinct transcriptional activation domains

1 reference

12 December 2020

10.1007/S12094-012-0784-4

Identifiers

DOI

1 reference

11 September 2017

1 reference

PubMed ID

22374423